Search results
Results from the WOW.Com Content Network
Commission Delegated Regulation (EU) 2016-960 of 17 May 2016 supplementing Regulation (EU) No 596-2014 of the European Parliament and of the Council with regard to regulatory technical standards for the appropriate arrangements, systems and procedures for disclosing market participants conducting market soundings (Text with EEA relevance)
Regulation No 548/2012/EU known as European Market infrastructure Regulation (EMIR): sets out rules regarding over-the-counter (OTC) derivative contracts, central counterparties and trade repositories. The main aim is to preserve stability in financial markets through risk mitigation and the introduction of new transparency requirements.
Commission Delegated Regulation (EU) 2016-522 of 17 December 2015 supplementing Regulation (EU) No 596-2014 of the European Parliament and of the Council as regards an exemption for certain third countries public bodies and central banks, the indicators of market manipulation, the disclosure thresholds, the competent authority for notifications of delays, the permission for trading during ...
Commission Implementing Regulation (EU) 2016-959 of 17 May 2016 laying down implementing technical standards for market soundings with regard to the systems and notification templates to be used by disclosing market participants and the format of the records in accordance with Regulation (EU) No 596-2014 of the European Parliament and of the Council (Text with EEA relevance)
Council Regulation 1638/98 made changes to the organisation of the olive oil market in the EU. [5] See Unión de Pequeños Agricultores; Council Regulation (EC) 2679/98 of 7 December 1998, on the functioning of the internal market in relation to the free movement of goods among the Member States, was aimed at preventing obstacles to the free movement of goods attributable to "action or ...
A qualified electronic signature is an electronic signature that is compliant with EU Regulation No 910/2014 (eIDAS Regulation) for electronic transactions within the internal European market. [1] It enables to verify the authorship of a declaration in electronic data exchange over long periods of time.
$737 million in fourth quarter and $2.2 billion in full year global product net sales. Received positive CHMP recommendation for VYVGART pre-filled syringe for gMG, enabling launch in the EU; FDA PDUFA (gMG and CIDP) on track for April 10
MIFID 2 (2014/65/EU) Art.25(4)[a] – Trading venues for the purposes of trading obligation for shares, in conjunction with Art. 23 of Regulation (EU) N° 600/2014 on markets in financial instruments (MIFIR): Australia, Hong Kong and the United States; Statutory Audit (2006/43/EC)